A Clinical Trial Assessing the Impact of the Availability of Inhaled Insulin on Glucose Control

Completed · Phase 3

Conditions studied: Diabetes Mellitus

In brief

To assess the impact on glucose control by inhaled insulin in patients with type 2 diabetes who are not well controlled on 2 or more oral anti-diabetic agents

Key facts

Study ID

NCT00134147

Run by

Pfizer

People needed

1100

Starts

2005-04-01

Expected to finish

2007-05-01

Last updated by the study team

2008-04-17

Who can join

Age: 35 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diabetes mellitus Type 2
• Failing two or more oral anti-diabetic agents

You may not qualify if…

• Asthma, COPD
• Smoking

Where it is running

• Pfizer Investigational Site — San Diego, California, United States
• Pfizer Investigational Site — Washington D.C., District of Columbia, United States
• Pfizer Investigational Site — Jacksonville, Florida, United States
• Pfizer Investigational Site — Jacksonville, Florida, United States
• Pfizer Investigational Site — Miami, Florida, United States
• Pfizer Investigational Site — Columbus, Georgia, United States
• Pfizer Investigational Site — Overland Park, Kansas, United States
• Pfizer Investigational Site — New Orleans, Louisiana, United States
• Pfizer Investigational Site — Baltimore, Maryland, United States
• Pfizer Investigational Site — Charlotte, North Carolina, United States
• Pfizer Investigational Site — Charlotte, North Carolina, United States
• Pfizer Investigational Site — Raleigh, North Carolina, United States
• Pfizer Investigational Site — Medford, Oregon, United States
• Pfizer Investigational Site — Hershey, Pennsylvania, United States
• Pfizer Investigational Site — Spartanburg, South Carolina, United States
• Pfizer Investigational Site — San Antonio, Texas, United States
• Pfizer Investigational Site — San Antonio, Texas, United States
• Pfizer Investigational Site — Calgary, Alberta, Canada
• Pfizer Investigational Site — Edmonton, Alberta, Canada
• Pfizer Investigational Site — Red Deer, Alberta, Canada
• Pfizer Investigational Site — Winnipeg, Manitoba, Canada
• Pfizer Investigational Site — Corunna, Ontario, Canada
• Pfizer Investigational Site — Oakville, Ontario, Canada
• Pfizer Investigational Site — Smith Falls, Ontario, Canada
• Pfizer Investigational Site — La Jolla, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.